Evidence map›Paper›PMID 36227120›Full record

ArticleMicrobiology spectrum2022

Acinetobacter nosocomialis Causes as Severe Disease as Acinetobacter baumannii in Northeast Thailand: Underestimated Role of A. nosocomialis in Infection.

Arnone Nithichanon, Chidchamai Kewcharoenwong, Hudadini Da-Oh, Sirithorn Surajinda, Aranya Khongmee, Surathinee Koosakunwat, Brendan W Wren, Richard A Stabler, Jeremy S Brown, Ganjana Lertmemongkolchai

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Phenotypic and genotypic characterization ofOne health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Genomic Diversity and Antimicrobial Resistance ofIndian journal of microbiology · 2025
    Article
  8. Biological Characteristics and Genomic Analysis ofCurrent issues in molecular biology · 2025
    Article
  9. Journal of tropical medicine · 2025
    Article
  10. Comparison ofInfection and drug resistance · 2025
    Article
  11. Article
  12. mBio · 2024
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Arnone NithichanonDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai Universitygrid.7132.7, Chiang Mai, Thailand.
Chidchamai KewcharoenwongDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai Universitygrid.7132.7, Chiang Mai, Thailand.
Hudadini Da-OhDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai Universitygrid.7132.7, Chiang Mai, Thailand.
Sirithorn SurajindaDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai Universitygrid.7132.7, Chiang Mai, Thailand.
Aranya KhongmeeCentre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen Universitygrid.9786.0, Khon Kaen, Thailand.
Surathinee KoosakunwatDepartment of Medicine, Nakhon Phanom Hospital, Nakhon Phanom, Thailand.
Brendan W WrenDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, Infectious and Tropical Disease, London, United Kingdom.ORCID 0000-0002-6140-9489
Richard A StablerDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, Infectious and Tropical Disease, London, United Kingdom.ORCID 0000-0002-2402-6630
Jeremy S BrownCentre for Inflammation and Tissue Repair, UCL Respiratory, London, United Kingdom.
Ganjana LertmemongkolchaiDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai Universitygrid.7132.7, Chiang Mai, Thailand.ORCID 0000-0001-6972-585X
Khon Kaen University · THChiang Mai University · THLondon School of Hygiene & Tropical Medicine · GBCentre for Inflammation Research · GBNakhon Phanom University · TH

Funding

Department of HealthMedical Research Council MRC DPFS MR/S004394/1Wellcome Trust 102979/Z/13/Z
6 · The paper itself

Abstract

Infections by Acinetobacter species are recognized as a serious global threat due to causing severe disease and their high levels of antibiotic resistance. Acinetobacter baumannii is the most prevalent pathogen in the genus, but infection by Acinetobacter nosocomialis has been reported widely. Diagnosis of patients with A. baumannii infection is often misdiagnosed with other Acinetobacter species, especially A. nosocomialis. This study investigated whether there were significant differences in clinical outcomes between patients infected with A. baumannii versus A. nosocomialis in Northeast Thailand, and to characterize serological responses to infection with these pathogens. The results show that A. baumannii had higher levels of multidrug resistance. Despite this, clinical outcomes for infection with A. baumannii or A. nosocomialis were similar with mortalities of 33% and 36%, respectively. Both pathogens caused community-acquired infections (A. baumannii 35% and A. nosocomialis 29% of cases). Plasma from uninfected healthy controls contained IgG antibody that recognized both organisms, and infected patients did not show a significantly enhanced antibody response from the first week versus 2 weeks later. Finally, the patterns of antigen recognition for plasma IgG were similar for patients infected with A. baumannii or A. nosocomialis infection, and distinct to the pattern for patients infected with non-Acinetobacter. In conclusion, our data revealed that infection with A. nosocomialis was associated with a similarly high level of mortality as infection with A. baumannii, the high rate of community-acquired infection and antibodies in uninfected individuals suggesting that there is significant community exposure to both pathogens.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsCommunity-Acquired InfectionsAcinetobacterAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsThailandAnti-Bacterial AgentsAcinetobacter baumanniiAcinetobacter nosocomialisantibodyantibody functionanti-microbial resistanceclinical severitycommunity-acquired infectionmultidrug resistance

Identifiers

PMID36227120
PMCPMC9769887
OpenAlexW4304976069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.